The Dizzying Journey to a New Cancer Arsenal

June 29, 2013

Science magazine profiles members of the research team behind Penn Medicine's efforts to develop a personalized cellular therapy to treat cancer, including Carl June, MD, David Porter, MD, and Bruce Levine, PhD. Though the history of early-stage clinical trials of this nature "may urge caution" the article notes, "it's hard not to be swept up in the moment. Despite the small numbers, many oncologists believe that what June's team and others now replicating it have seen is unprecedented. No cell therapy has proliferated in the body, endured, and slain cancer quite like this one."

Science magazine article